Table 3 Distribution of cardiovascular risk categories and estimated costs associated with treatment of hypertension, dyslipidemia and diabetes mellitus
Cost | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
2004 | 2005 | |||||||||
Condition/criterion | Associated conditions | Risk* | Medication | Prevalence in population aged 25–64 (%) | Cost per day per treated patient (SCR) | Annual cost for all cases aged ≥25 yrs (SCR million) | Per capita cost for total population per year (US$) | Cost per day per treated patient (SCR) | Annual cost for all cases aged ≥25 yrs (SCR million) | Per capita cost for total population per year (US$) |
Diabetes (DM) | ||||||||||
FBG ≥10 mmol/l | High | Metformin 1.5 g/d & Glibenclamide 10 mg/d | 4.9 | 6.05 | 4.95 | 12.4 | 0.66 | 0.54 | 1.3 | |
Addition of insulin 20 U (in 10% of cases) | 3.40 | 0.28 | 0.7 | 7.72 | 0.63 | 1.6 | ||||
FBG 7–9 mmol/l | High | Metformin 1.5 g/d | 3.6 | 4.83 | 2.92 | 7.3 | 0.48 | 0.29 | 0.7 | |
FBG <7 mmol/l | Treatment for DM | High | Metformin 1 g/d | 0.9 | 3.19 | 0.45 | 1.1 | 0.32 | 0.05 | 0.1 |
Total diabetes | 9.3 | 8.60 | 21.5 | 1.51 | 3.8 | |||||
Hypertension | ||||||||||
≥180/110 mmHg | - | High | 2 drugs (20%), 3 drugs (70%), 4 drugs (10%) | 3.1 | 4.10 | 2.11 | 5.3 | 1.47 | 0.76 | 1.9 |
160–179/100–109 | ≥3 MRF or DM | High | 2 drugs (60%), 3 drugs (30%), 4 drugs (10%) | 2.3 | 3.47 | 1.33 | 3.3 | 1.26 | 0.48 | 1.2 |
160–179/100–109 | 0–2 MRF, not DM | Medium | 1 drug (10%), 2 drugs (60%), 3 drugs (30%) | 5.6 | 2.78 | 2.63 | 6.6 | 1.01 | 0.96 | 2.4 |
140–159/90–99 | ≥3 MRF or DM | High | 1 drug (20%), 2 drugs (70%), 3 drugs (10%) | 5.6 | 2.27 | 2.14 | 5.4 | 0.83 | 0.79 | 2.0 |
140–159/90–99 | 1–2 MRF, not DM | Medium | 1 drug (60%), 2 drugs (40%) | 12.1 | 1.32 | 2.67 | 6.7 | 0.50 | 1.01 | 2.5 |
140–159/90–99 | 0 MRF | Low | - | 4.3 | 0 | 0 | ||||
<140/90 | Treatment and ≥1 MRF | ≥Medium | 1 drug (70%), 2 drugs (30%) | 6.9 | 1.12 | 1.28 | 3.2 | 0.43 | 0.49 | 1.2 |
Total hypertension | 39.9 | 12.16 | 30.4 | 4.48 | 11.2 | |||||
High cholesterol | ||||||||||
≥8 mmol/l | High | Rosuvastatin 10 mg/d (80%), 20 mg (20%) | 3.1 | 9.37 | 4.80 | 12.0 | 8.77 | 4.49 | 11.2 | |
7–7.9 mmol/l | ≥2 MRF or DM | High | Rosuvastatin 10 mg/d | 3.5 | 7.81 | 4.56 | 11.4 | 7.31 | 4.27 | 10.7 |
6–6.9 mmol/l | ≥3 MRF or DM | High | Rosuvastatin 10 mg/d | 2.8 | 7.81 | 3.71 | 9.3 | 7.31 | 3.47 | 8.7 |
Total dyslipidemia | 9.4 | 13.07 | 32.7 | 12.24 | 30.6 | |||||
Any condition | 42.7 | 33.8 | 84.6 | 18.22 | 45.6 | |||||